Dataset Information


1H NMR-Based Metabolomics Reveals the Antitumor Mechanisms of Triptolide in BALB/c Mice Bearing CT26 Tumors.

ABSTRACT: Triptolide, the main active ingredient in Tripterygium wilfordii Hook. f. (Celastraceae), has shown promising effects against a variety of tumors. However, the molecular pharmacological mechanisms explaining the action of triptolide remain unknown. In this study, the CT26 colon tumor cell line was inoculated subcutaneously into BALB/c mice, and plasma samples were subjected to 1H NMR metabolomics analysis. The metabolic signature identified five metabolites whose levels were lower and 15 whose levels were higher in CT26 tumor-bearing mice than in normal control mice. Triptolide treatment significantly reversed the levels of nine of these metabolites, including isoleucine, glutamine, methionine, proline, 3-hydroxybutyric acid, 2-hydroxyisovalerate, 2-hydroxyisobutyrate, and low-density lipoprotein/very low-density lipoprotein. Based on the identities of these potential biomarkers, we conclude that the antitumor mechanism of triptolide might rely on correcting perturbations in branched-chain amino acid metabolism, serine/glycine/methionine biosynthesis, and ketone bodies metabolism.


PROVIDER: S-EPMC6798008 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7037371 | BioStudies
2014-01-01 | S-EPMC4813726 | BioStudies
2011-01-01 | S-EPMC3503517 | BioStudies
1986-01-01 | S-EPMC1153077 | BioStudies
2014-01-01 | S-EPMC4079517 | BioStudies
2012-01-01 | S-EPMC3422234 | BioStudies
1000-01-01 | S-EPMC6052061 | BioStudies
1000-01-01 | S-EPMC5395814 | BioStudies
2021-11-20 | GSE189092 | GEO
2019-01-01 | S-EPMC7062010 | BioStudies